Tuesday, 13 October 2020

Global Genotyping Market Positive Growth And Forecasts By 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Genotyping Market over the forecast period.

Genotyping services help to understand the genetic structure of any living organisms such as humans, animals, plants, and microorganisms. Human genotyping provides data related to the genetic history of an individual; microorganism genotyping provide aid in research and development of bacterial and viral diseases.

Also Read : https://www.medgadget.com/2019/01/genotyping-market-opportunities-technological-developments-and-trends-2019-marketresearchfuture-brief-insights-to-2023.html 

Global Genotyping Market accounted for USD 6120 million in 2015 and expected to register healthy growth during the forecast period (2018–2023) at a CAGR of 22.5%.

Some of the key players in the global genotyping market are QIAGEN, Affymetrix, Inc., Illumina, Inc, Thermo Fisher Scientific, Inc., General Electric Company, Agilent Technologies, Inc., Fluidigm Corporation, Sequenom, F. Hoffmann-La Roche Ltd, and Beckman Coulter, Inc.

Global Genotyping Market has been segmented on the basis of technology, product, application, and end-user.

On the basis of technology, the market has been classified as sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.

The product segment has been divided into reagents and kits, instruments, and services.

The application segment has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.

by end-user, has been segmented into hospitals, diagnostic centers, academic institutes, and research and development centers.

Geographically, market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The genotyping market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European genotyping market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The genotyping market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The genotyping market in the Middle East & Africa has been segmented into the Middle East and Africa.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/genotyping-market-6635

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

No comments:

Post a Comment